StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
EXPLEOSOL.BO$875.65+0.35%
Fair $875.65+0.0%

EXPLEOSOL.BO

Expleo Solutions Limited

Technology / Information Technology ServicesBSE

$875.65

+3.05 (+0.35%)

Fairly Valued+0.0%Fair Value $875.65Fund rank 31/100 · Data gapFallback financials|
SA 62/B
F-Score: 5/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 32% · confianza 25%

FCF escenarios

weak_data · normalized FCF $1.2B · quality 57.7/100

Data gap 31/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 40/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

62/100

B

Piotroski

5/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · EXPLEOSOL.BOLocal privado en este navegador · Expleo Solutions Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$13.6B

P/E

11.0x

↓

EV/EBITDA

5.2x

↓

ROE

16.0%

↑

Gross Margin

36.4%

↑

Debt/Equity

0.01

↓
52-Week Range$876
$644$1366

TradingView lightweight chart

EXPLEOSOL.BO price, volumen y niveles de valoración

Último $875.65Periodo +433.0%
Fair value: $875.65

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2023–2026 · 3 años de histórico normalizado

Revenue CAGR

+7.0%

FCF CAGR

—

FCF margin

10.5%

FCF / Net income

0.94x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $11.08B · net income $1.24B · FCF $1.17B

2023-FY → 2026-FY

Gross margin

36.4%-12.8% pts

Operating margin

12.8%-6.4% pts

Net margin

11.2%-3.6% pts

FCF margin

10.5%+12.9% pts
MetricTTM
2026
2025
2024
2023
Income Statement
Revenue$11.08B$11.08B$10.25B$9.65B$9.03B
Net Income$1.24B$1.24B$1.03B$904.4M$1.34B
EBITDA$1.93B$1.93B$1.82B$1.56B$2.16B
EPS79.8979.8966.5258.2786.27
Gross Margin36.4%36.4%40.0%43.2%49.2%
Operating Margin12.8%12.8%12.5%11.9%19.2%
Net Margin11.2%11.2%10.1%9.4%14.8%
Balance Sheet
Debt/Equity0.010.010.050.040.05
Current Ratio5.555.55———
Cash Flow
Free Cash Flow$1.17B$1.17B$1.72B$538.6M$-211.1M
Returns
ROE16.0%16.0%16.2%14.8%25.3%
Valuation
P/E10.9610.9611.9022.7614.75
EV/EBITDA5.245.245.7312.248.55
P/B1.751.751.933.373.73
Growth & Yield
Revenue Growth8.1%8.1%6.2%6.8%—
EPS Growth20.1%20.1%14.2%-32.5%—
Dividend Yield5.6%5.6%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

-0.9%

fácil

EPS terminal req.

$77.70

Spread vs growth

21.0%

5Y implied EPS CAGR

3.3%

fácil

EPS terminal req.

$94.02

Spread vs growth

16.8%

10Y implied EPS CAGR

6.6%

razonable

EPS terminal req.

$151.41

Spread vs growth

13.5%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -8.5%

Total return

-8.5%

Start / end P/E

15.3x → 11.0x

EPS bridge

66.52 → 79.89

Residual

-5.7%

EPS growth+20.1%
Multiple rerating-28.5%
Dividend+5.6%
Residual / FX / buybacks / cross-term-5.7%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.